Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Jul 25. pii: annrheumdis-2018-213512. doi: 10.1136/annrheumdis-2018-213512. [Epub ahead of print]

2.

Therapeutic Guidelines for Latin American Lupus Patients: Methodology.

Cardiel MH, Soriano ER, Bonfá ESDO, Alarcón GS, Izcovich A, Amigo Castañeda MC, Barile-Fabris LA, Duarte M, Espada G, García MA, Levy RA, Massardo L, Sato EI, Vásquez G, Acevedo-Vásquez EM, Catoggio LJ, Chacón-Díaz R, Galarza Maldonado CM, Iglesias Gamarra AJ, Molina Restrepo JF, Neira O, Silva CA, Vargas Peña A, Pons-Estel BA.

J Clin Rheumatol. 2018 Jan;24(1):41-44. doi: 10.1097/RHU.0000000000000662. No abstract available.

PMID:
29200029
3.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
4.

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2018 Apr;27(4):536-544. doi: 10.1177/0961203317728810. Epub 2017 Aug 31.

PMID:
28857715
5.

Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017.

Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune A Neto, Bertolami A, Pereira AC, Lottenberg AM, Sposito AC, Chagas ACP, Casella A Filho, Simão AF, Alencar AC Filho, Caramelli B, Magalhães CC, Negrão CE, Ferreira CEDS, Scherr C, Feio CMA, Kovacs C, Araújo DB, Magnoni D, Calderaro D, Gualandro DM, Mello EP Junior, Alexandre ERG, Sato EI, Moriguchi EH, Rached FH, Santos FCD, Cesena FHY, Fonseca FAH, Fonseca HARD, Xavier HT, Mota ICP, Giuliano ICB, Issa JS, Diament J, Pesquero JB, Santos JED, Faria JR Neto, Melo JX Filho, Kato JT, Torres KP, Bertolami MC, Assad MHV, Miname MH, Scartezini M, Forti NA, Coelho OR, Maranhão RC, Santos RDD Filho, Alves RJ, Cassani RL, Betti RTB, Carvalho T, Martinez TLDR, Giraldez VZR, Salgado W Filho.

Arq Bras Cardiol. 2017 Jul;109(2 Supl 1):1-76. doi: 10.5935/abc.20170121. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2017 Nov;109 (5):499.

6.

The Influence of Income and Formal Education on Damage in Brazilian Patients With Systemic Lupus Erythematosus.

Teixeira RCA, Borba Neto EF, Christopoulos GB, Sato EI.

J Clin Rheumatol. 2017 Aug;23(5):246-251. doi: 10.1097/RHU.0000000000000541.

PMID:
28700531
7.

Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Pons-Estel GJ, Soriano ER, Saurit V, Sato EI, Lavras Costallat LT, Molina JF, Iglesias-Gamarra A, Reyes-Llerena G, Neira OJ, Barile LA, Silveira LH, Segami MI, Chacón-Díaz R, Wojdyla D, Alarcón GS, Pons-Estel BA.

Semin Arthritis Rheum. 2017 Oct;47(2):199-203. doi: 10.1016/j.semarthrit.2017.01.012. Epub 2017 Feb 2.

PMID:
28291583
8.

The relevance of performing exercise test before starting supervised physical exercise in asymptomatic cardiovascular patients with rheumatic diseases.

Klemz BN, Reis-Neto ET, Jennings F, Siqueira US, Klemz FK, Pinheiro HH, Sato EI, Natour J, Szejnfeld VL, Pinheiro MM.

Rheumatology (Oxford). 2016 Nov;55(11):1978-1986. Epub 2016 Aug 1.

PMID:
27481271
9.

Leflunomide in Takayasu arteritis - A long term observational study.

de Souza AW, de Almeida Agustinelli R, de Cinque Almeida H, Oliveira PB, Pinheiro FA, Oliveira AC, Sato EI.

Rev Bras Reumatol Engl Ed. 2016 Jul-Aug;56(4):371-5. doi: 10.1016/j.rbre.2016.02.003. Epub 2016 Mar 2. English, Portuguese.

10.

(18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis.

Arraes AE, de Souza AW, Mariz HA, Silva NP, Torres IC, Pinto PN, Lima EN, Sato EI.

Rev Bras Reumatol Engl Ed. 2016 Jul-Aug;56(4):299-308. doi: 10.1016/j.rbre.2015.08.007. Epub 2015 Sep 9. English, Portuguese.

11.

Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.

Pons-Estel GJ, Aspey LD, Bao G, Pons-Estel BA, Wojdyla D, Saurit V, Alvarellos A, Caeiro F, Haye Salinas MJ, Sato EI, Soriano ER, Costallat LT, Neira O, Iglesias-Gamarra A, Reyes-Llerena G, Cardiel MH, Acevedo-Vásquez EM, Chacón-Díaz R, Drenkard C.

Lupus. 2017 Jan;26(1):73-83. Epub 2016 May 26.

PMID:
27230554
12.

Leflunomide in Takayasu arteritis - A long term observational study.

de Souza AW, de Almeida Agustinelli R, de Cinque Almeida H, Oliveira PB, Pinheiro FA, Oliveira AC, Sato EI.

Rev Bras Reumatol. 2016 Feb 5. pii: S0482-5004(16)00005-X. doi: 10.1016/j.rbr.2015.09.007. [Epub ahead of print] English, Portuguese.

13.

Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.

Ferreira GA, Teixeira AL, Calderaro DC, Sato EI.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):42-8. Epub 2015 Nov 17.

PMID:
26574625
14.

A Study of Multiple Causes of Death in Rheumatoid Arthritis.

Pinheiro FA, Souza DC, Sato EI.

J Rheumatol. 2015 Dec;42(12):2221-8. doi: 10.3899/jrheum.150166. Epub 2015 Oct 15.

PMID:
26472415
15.

[18F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis].

Arraes AE, de Souza AW, Mariz HA, Silva NP, Torres IC, Pinto PN, Lima EN, Sato EI.

Rev Bras Reumatol. 2015 Jul 30. pii: S0482-5004(15)00093-5. doi: 10.1016/j.rbr.2015.03.009. [Epub ahead of print] Portuguese.

16.

Visual loss resulting from immunosuppressive therapy in patients with syphilitic uveitis.

Afonso VC, Nascimento H, Belfort RM, Sato EI, Muccioli C, Belfort R Jr.

Arq Bras Oftalmol. 2015 May-Jun;78(3):185-6. doi: 10.5935/0004-2749.20150047.

17.

High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.

de Souza AW, van der Geest KS, Brouwer E, Pinheiro FA, Oliveira AC, Sato EI, Andrade LE, Bijl M, Westra J, Kallenberg CG.

Arthritis Res Ther. 2015 Jun 12;17:158. doi: 10.1186/s13075-015-0672-8.

18.

Evaluation of functional capacity in individuals with signs and symptoms of musculoskeletal disease: results of the BRAZCO population study (Brazilian COPCORD Study).

Jennings F, Sato EI, da Rocha Castelar Pinheiro G, Ferraz MB.

Rheumatol Int. 2015 Nov;35(11):1873-9. doi: 10.1007/s00296-015-3299-9. Epub 2015 Jun 9.

PMID:
26055534
19.

Prevalence of musculoskeletal symptoms in the five urban regions of Brazil-the Brazilian COPCORD study (BRAZCO).

Dos Reis-Neto ET, Ferraz MB, Kowalski SC, Pinheiro Gda R, Sato EI.

Clin Rheumatol. 2016 May;35(5):1217-23. doi: 10.1007/s10067-015-2963-5. Epub 2015 May 12.

PMID:
25963999
20.

Brazilian urban population norms derived from the health-related quality of life SF-6D.

Ciconelli RM, Ferraz MB, Kowalski S, Pinheiro Gda R, Sato EI.

Qual Life Res. 2015 Oct;24(10):2559-64. doi: 10.1007/s11136-015-0991-x. Epub 2015 Apr 18.

PMID:
25894065
21.

Perceptions of the population regarding generic drugs in Brazil: a nationwide survey.

Nardi EP, Ferraz MB, Pinheiro GR, Kowalski SC, Sato EI.

BMC Public Health. 2015 Feb 10;15:117. doi: 10.1186/s12889-015-1475-1.

22.

[Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis].

Klumb EM, Silva CA, Lanna CC, Sato EI, Borba EF, Brenol JC, de Albuquerque EM, Monticielo OA, Costallat LT, Latorre LC, Sauma Mde F, Bonfá ES, Ribeiro FM.

Rev Bras Reumatol. 2015 Jan-Feb;55(1):1-21. doi: 10.1016/j.rbr.2014.09.008. Epub 2014 Nov 1. Portuguese.

23.

Long-term persistence of anti-β2 glycoprotein I in treated leprosy patients.

Ribeiro SL, Pereira HL, Silva NP, Sato EI, Passos LF, Dos-Santos MC.

Lupus. 2014 Oct;23(12):1249-51. doi: 10.1177/0961203314529469.

PMID:
25228717
24.

Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.

García MA, Alarcón GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JC, Massardo L, Molina-Restrepo JF, Vásquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yáñez GF, Cucho-Venegas JM, Chacón-Diaz R, Pons-Estel BA; Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL).

Rheumatology (Oxford). 2014 Aug;53(8):1431-8. doi: 10.1093/rheumatology/keu011. Epub 2014 Mar 14.

PMID:
24633413
25.

The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.

da Silva AE, dos Reis-Neto ET, da Silva NP, Sato EI.

Lupus. 2013 Dec;22(14):1479-83. doi: 10.1177/0961203313508832. Epub 2013 Oct 17.

PMID:
24135080
26.

Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.

dos Reis-Neto ET, da Silva AE, Monteiro CM, de Camargo LM, Sato EI.

Rheumatology (Oxford). 2013 Dec;52(12):2187-95. doi: 10.1093/rheumatology/ket283. Epub 2013 Aug 22.

PMID:
23970541
27.

Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study.

de Souza AW, Keusseyan SP, da Silva NP, Sato EI, Andrade LE.

Rev Bras Reumatol. 2012 May-Jun;52(3):357-65. English, Portuguese.

28.

Oral microbial colonization in patients with systemic lupus erythematous: correlation with treatment and disease activity.

de Araújo Navas EA, Sato EI, Pereira DF, Back-Brito GN, Ishikawa JA, Jorge AO, Brighenti FL, Koga-Ito CY.

Lupus. 2012 Aug;21(9):969-77. doi: 10.1177/0961203312443420. Epub 2012 Mar 27.

PMID:
22453994
29.

Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.

de Souza AW, da Silva MD, Machado LS, Oliveira AC, Pinheiro FA, Sato EI.

Scand J Rheumatol. 2012 May;41(3):227-30. doi: 10.3109/03009742.2011.633553. Epub 2012 Mar 9.

PMID:
22400913
30.

Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.

Souza DC, Santo AH, Sato EI.

J Rheumatol. 2012 Mar;39(3):496-503. doi: 10.3899/jrheum.110241. Epub 2012 Jan 15.

PMID:
22247362
31.

Anti-β2-glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients.

Ribeiro SL, Pereira HL, Silva NP, Souza AW, Sato EI.

Acta Reumatol Port. 2011 Jan-Mar;36(1):30-7.

32.

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions.

Carneiro JR, Fuzii HT, Kayser C, Alberto FL, Soares FA, Sato EI, Andrade LE.

Clinics (Sao Paulo). 2011;66(1):77-82.

33.

Increased myeloperoxidase plasma levels in rheumatoid arthritis.

Fernandes RM, da Silva NP, Sato EI.

Rheumatol Int. 2012 Jun;32(6):1605-9. doi: 10.1007/s00296-011-1810-5. Epub 2011 Feb 18.

PMID:
21331575
34.

Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.

Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE.

Arthritis Rheum. 2011 Jan;63(1):191-200. doi: 10.1002/art.30084. Erratum in: Arthritis Rheum. 2011 May;63(5):1468.

35.

Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.

Santo AH, Souza JM, Pinheiro CE, Souza DC, Sato EI.

BMC Public Health. 2010 Oct 11;10:597. doi: 10.1186/1471-2458-10-597.

36.

Central auditory processing in patients with systemic lupus erythematosus.

Bruner AP, Sato EI, Pereira LD.

Acta Reumatol Port. 2009 Oct-Dec;34(4):600-7.

37.

Trends in systemic lupus erythematosus mortality rates in the state of Sao Paulo, Brazil from 1985 to 2004.

Souza DC, Santo AH, Sato EI.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):519-24. Epub 2010 Aug 30.

PMID:
20659407
38.

Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis.

de Souza AW, Machado NP, Pereira VM, Arraes AE, Reis Neto ET, Mariz HA, Sato EI.

Circ J. 2010 Jun;74(6):1236-41. Epub 2010 May 8.

39.

Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.

Ferreira GA, Teixeira AL, Sato EI.

Lupus. 2010 Jul;19(8):927-34. doi: 10.1177/0961203310364400. Epub 2010 Apr 21.

PMID:
20410153
40.

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

Shinjo SK, Bonfá E, Wojdyla D, Borba EF, Ramirez LA, Scherbarth HR, Brenol JC, Chacón-Diaz R, Neira OJ, Berbotto GA, De La Torre IG, Acevedo-Vázquez EM, Massardo L, Barile-Fabris LA, Caeiro F, Silveira LH, Sato EI, Buliubasich S, Alarcón GS, Pons-Estel BA; Grupo Latino Americano de Estudio del Lupus Eritematoso (Gladel).

Arthritis Rheum. 2010 Mar;62(3):855-62. doi: 10.1002/art.27300.

41.

Increased plasma myeloperoxidase levels in systemic lupus erythematosus.

Telles RW, Ferreira GA, da Silva NP, Sato EI.

Rheumatol Int. 2010 Apr;30(6):779-84. doi: 10.1007/s00296-009-1067-4. Epub 2009 Jul 29.

PMID:
19639322
42.

Thoracic outlet syndrome (TOS) mimicking Takayasu's arteritis--case report.

dos Reis Neto ET, Pucinelli ML, Silva de Souza AW, Sato EI.

Acta Reumatol Port. 2009 Jan-Mar;34(1):96-101.

43.

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.

Ribeiro SL, Pereira HL, Silva NP, Neves RM, Sato EI.

Braz J Med Biol Res. 2008 Nov;41(11):1005-10.

44.

[Rheumatic manifestations in leprosy].

Pereira HL, Ribeiro SL, Sato EI.

Acta Reumatol Port. 2008 Oct-Dec;33(4):407-14. Review. Portuguese.

45.

Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients.

de Souza AW, Ataíde Mariz H, Torres Reis Neto E, Diniz Arraes AE, da Silva NP, Sato EI.

Clin Rheumatol. 2009 Apr;28(4):379-83. doi: 10.1007/s10067-008-1056-0. Epub 2008 Dec 5.

PMID:
19057845
46.

Leprosy-related joint involvement.

Pereira HL, Ribeiro SL, Pennini SN, Sato EI.

Clin Rheumatol. 2009 Jan;28(1):79-84. doi: 10.1007/s10067-008-0986-x. Epub 2008 Sep 19.

PMID:
18807102
47.

Vitamin D deficiency in patients with active systemic lupus erythematosus.

Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M.

Osteoporos Int. 2009 Mar;20(3):427-33. doi: 10.1007/s00198-008-0676-1. Epub 2008 Jul 4.

PMID:
18600287
48.

Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.

de Souza AW, Silva NP, de Carvalho JF, D'Almeida V, Noguti MA, Sato EI.

Lupus. 2007;16(10):782-7.

PMID:
17895300
49.

Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.

Ferreira GA, Navarro TP, Telles RW, Andrade LE, Sato EI.

Rheumatology (Oxford). 2007 Oct;46(10):1560-5. Epub 2007 Aug 10.

PMID:
17693444
50.

Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.

Carvalho MR, Sato EI, Tebexreni AS, Heidecher RT, Schenkman S, Neto TL.

Arthritis Rheum. 2005 Dec 15;53(6):838-44.

Supplemental Content

Support Center